Human Milk Oligosaccharide Market Outlook: Reaching US$ 161.6 Million by 2034

The global human milk oligosaccharide (HMO) market is estimated to reach US$ 100.8 million in 2024. Over the forecast period, human milk oligosaccharide sales are poised to increase at a CAGR of 6.5%. The global industry is estimated to reach a value of US$ 161.6 million by 2034.

The Human Milk Oligosaccharides (HMO) Market is expanding rapidly as the health benefits of HMOs become more widely known. These complex carbohydrates contained in breast milk play an important role in baby gut health and immunity. Growing research, technological developments, and increased demand for functional ingredients are propelling the industry forward.

Get our Report Sample Now and Elevate Your Understanding.
https://www.futuremarketinsights.com/reports/sample/rep-gb-4252

In 2017 and beyond, the human milk oligosaccharides market in Europe is anticipated to witness significant revenue growth. Towards the end of 2027, Europe is anticipated to account for over 49% value share of the global market. Manufacturers in Europe are filing claims for regulatory approvals and product safety certifications in order to use HMO for preparing infant formulas. In North America, the HMO market is currently valued at over US$ 6 Mn and holds the second spot in terms of market size after Europe.

FMI’s report, titled “Human Milk Oligosaccharides Market Global Industry Analysis and Opportunity Assessment, 2017 – 2027” also cites that demand for HMO is gaining traction due to a positive perception of its prebiotic properties that help maintain a healthy immune system in infants. In addition, manufacturers are focusing on increasing their production capacities in order to enhance production of HMOs such as 2’-FL (2-fucosyllactose) that can be potentially used as an ingredient in functional food and beverages. zuChem Inc., Glycosyn LLC, Elicityl SA, Jennewein Biotechnologie GmbH, Glycom A/S, Dextra Laboratories Limited, Carbosynth Limited, Inbiose NV, ProZyme, Inc. are the leading companies operating in the global human milk oligosaccharides market.

Key Excerpts of the Report Include:

  • Among product type, fucosyllactose HMO currently accounts for the largest value share of the market followed by sialyllactose HMO. However, the latter is expected to register a faster growth rate in terms of the market value over the forecast period.
  • By 2017-end, US$ 5.5 Mn worth sialyllactose HMO is expected to be consumed globally.
  • Increasing demand for functional food and beverage products is projected to further facilitate the growth of global human milk oligosaccharides market over the next couple of years.

Market Segmentation

By Product Type

  • Fucosyllactose
  • LNT & LNnT
  • Sialyllactose

By Region

  • North America
  • Europe
  • Asia Pacific

Request Your Personalized Report and Harness the Power of Informed Decision-Making
https://www.futuremarketinsights.com/customization-available/rep-gb-4252

Frequently Asked Questions

  • How big is the Human Milk Oligosaccharides Market?
  • At What Rate is Human Milk Oligosaccharides Market expected to rise?
  • What is the North America, Human Milk Oligosaccharides Market Outlook?
  • Which are the major countries driving demand for Human Milk Oligosaccharides Market?
  • At what rate will the China Human Milk Oligosaccharides Market grow?
  • At what rate will the Germany Human Milk Oligosaccharides Market grow?
  • At What Rate will, Human Milk Oligosaccharides Market Demand Grow in Europe?
  • Who are the top 5 players operating in the market?
  • At what rate will the Mexico Human Milk Oligosaccharides Market grow?
  • What is the outlook forecast for the Human Milk Oligosaccharides Market?

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *